Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study

Fig. 2

ACR20, ACR50 and ACR70 responses. a Proportion of patients with an ACR20 response in the ITT population and the PPS population at week 24, and proportion of patients achieving a clinical response according to b ACR20, c ACR50 and d ACR70 in the ITT population over time. Error bars represent standard error. ACR American College of Rheumatology, ITT intention-to-treat, PPS per-protocol set

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us